(Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced the publication of results from a prior Phase 2 clinical study evaluating ...
Patients with hematologic disease are at an elevated risk of morbidity and mortality post-infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. It is currently unknown ...
Cost-Effectiveness of Next-Generation Sequencing Versus Single-Gene Testing for the Molecular Diagnosis of Patients With Metastatic Non–Small-Cell Lung Cancer From the Perspective of Spanish Reference ...
Poster presentations at ASH highlight advances in the understanding and research of Castleman disease, cold agglutinin disease, B-cell lymphoma, and other hematologic conditions "We are particularly ...
Jennifer Vidrine, MBBS, MRCP, of Newcastle upon Tyne Hospitals, stresses the importance of providing personalized, beneficial end-of-life care for patients with hematologic diseases. Jennifer Vidrine, ...
At Huntsman Cancer Institute, you receive expert, highly specialized care for benign bleeding and clotting disorders. Your care team includes hematologists, nurse coordinators, social workers, ...
Ana Lacerda, MD, MSc, of the Portuguese Institute of Oncology, advocates for early palliative care integration in pediatric patients with hematologic diseases. Improving end-of-life care for pediatric ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results